All-trans-retinoic acid (ATRA) affects aldehyde dehydrogenase 1 (ALDH1) activity, which is considered a key marker of malignant cancer stem cells, including ovarian cancer [11]. This evidence concerns the gene ALDH1A1 and ovarian carcinoma.